Sex-Specific Variations in the mRNA Levels of Candidate Genes in Peripheral Blood Mononuclear Cells from Patients with Diabetes: A Multistep Study

References

• Mouri M, Badireddy M. Hyperglycemia. In StatPearls. StatPearls Publishing. 2023.
   Google Scholar
• Graber R, Farine JC, Fumagalli I, Tatti V, Losa GA. Apoptosis and oxidative status in peripheral blood mononuclear cells of diabetic patients. Apoptosis. 1999;4(4):263–270.
   PubMed Web of Science ®Google Scholar
• Ahmed S, Clark A, Matthews DR. Progressive decline of β-cell function in non-insulin dependent diabetes. Curr Opin Endocrinol Diabetes Obes. 1997;4(4):300–307. doi:10.1097/00060793-199708000-00008.
   Google Scholar
• Kurano M, Darestani SG, Shinnakasu A, et al. mRNA expression of platelet activating factor receptor (PAFR) in peripheral blood mononuclear cells is associated with albuminuria and vascular dysfunction in patients with type 2 diabetes. Diabetes Res Clin Pract. 2018;136:124–133. doi:10.1016/j.diabres.2017.11.028.
   PubMed Web of Science ®Google Scholar
• Ghavidel Darestani S, Kurano M, Shinnakasu A, et al. Association between changes in the mRNA expression of platelet-activating factor receptor in peripheral blood mononuclear cells and progression of diabetic nephropathy. Diabetol Int. 2019;11(1):11–18. doi:10.1007/s13340-019-00394-w.
   PubMed Web of Science ®Google Scholar
• Nakagawa T, Tanabe K, Croker BP, et al. Endothelial dysfunction as a potential contributor in diabetic nephropathy. Nat Rev Nephrol. 2011;7(1):36–44. doi:10.1038/nrneph.2010.152.
   PubMed Web of Science ®Google Scholar
• Takamura T, Honda M, Sakai Y, et al. Gene expression profiles in peripheral blood mononuclear cells reflect the pathophysiology of type 2 diabetes. Biochem Biophys Res Commun. 2007;361(2):379–384. doi:10.1016/j.bbrc.2007.07.006.
   PubMed Web of Science ®Google Scholar
• Duran-Salgado MB, Rubio-Guerra AF. Diabetic nephropathy and inflammation. World J Diabetes. 2014;5(3):393–398. doi:10.4239/wjd.v5.i3.393.
   PubMedGoogle Scholar
• Wada J, Makino H. Inflammation and the pathogenesis of diabetic nephropathy. Clin Sci. 2013;124(3):139–152. doi:10.1042/CS20120198.
   PubMed Web of Science ®Google Scholar
• Moczulski DK, Fojcik H, Wielgorecki A, et al. Expression pattern of genes in peripheral blood mononuclear cells in diabetic nephropathy. Diabet Med. 2007;24(3):266–271. doi:10.1111/j.1464-5491.2006.02067.x.
   PubMed Web of Science ®Google Scholar
• Kempf K, Rose B, Herder C, et al. The metabolic syndrome sensitizes leukocytes for glucose-induced immune gene expression. J Mol Med. 2007;85(4):389–396. doi:10.1007/s00109-006-0132-7.
   PubMed Web of Science ®Google Scholar
• Li T, Quan H, Zhang H, et al. Type 2 diabetes is more predictable in women than men by multiple anthropometric and biochemical measures. Sci Rep. 2021;11(1):6062. doi:10.1038/s41598-021-85581-z.
   PubMed Web of Science ®Google Scholar
• Regitz-Zagrosek V. Sex and gender differences in health. Science & society series on sex and science. EMBO Rep. 2012;13(7):596–603. doi:10.1038/embor.2012.87.
   PubMed Web of Science ®Google Scholar
• Kautzky-Willer A, Harreiter J, Pacini G. Sex and gender differences in risk, pathophysiology and complications of type 2 diabetes mellitus. Endocr Rev. 2016;37(3):278–316. doi:10.1210/er.2015-1137.
   PubMed Web of Science ®Google Scholar
• Peters SAE, Woodward M. Sex differences in the burden and complications of diabetes. Curr Diab Rep. 2018;18(6):33. doi:10.1007/s11892-018-1005-5.
   PubMed Web of Science ®Google Scholar
• PE W, AC C. Gender differences and time trends in incidence and prevalence of type 2 diabetes in Sweden—A model explaining the diabetes epidemic worldwide today? Diabetes Res Clin Pract. 2014;106(3):90–92. doi:10.1016/j.diabres.2014.09.013.
   Web of Science ®Google Scholar
• Juutilainen A, Kortelainen S, Lehto S, Rönnemaa T, Pyörälä K, Laakso M. Gender difference in the impact of type 2 diabetes on coronary heart disease risk. Diabetes Care. 2004;27(12):2898–2904. doi:10.2337/diacare.27.12.2898.
   PubMed Web of Science ®Google Scholar
• Sattar N. Gender aspects in type 2 diabetes mellitus and cardiometabolic risk. Best Pract Res Clin Endocrinol Metab. 2013;27(4):501–507. doi:10.1016/j.beem.2013.05.006.
   PubMed Web of Science ®Google Scholar
• Paul S, Thomas G, Majeed A, Khunti K, Klein K. Women develop type 2 diabetes at a higher body mass index than men. Diabetologia. 2012;55(5):1556–1557. doi:10.1007/s00125-012-2496-2.
   PubMed Web of Science ®Google Scholar
• Stadlmayr A, Aigner E, Huber-Schönauer U, Niederseer D, Zwerina J, Husar-Memmer E, et al. Relations of vitamin D status, gender and type 2 diabetes in middle-aged Caucasians. Acta Diabetol. 2015;52(1):39–46. doi:10.1007/s00592-014-0596-9.
   PubMed Web of Science ®Google Scholar
• Kowsar R, Mansouri A. Multi-level analysis reveals the association between diabetes, body mass index, and HbA1c in an Iraqi population. Sci Rep. 2022;12(1):21135. doi:10.1038/s41598-022-25813-y.
   PubMedGoogle Scholar
• Kowsar R, Keshtegar B, Miyamoto A. Understanding the hidden relations between pro-and anti-inflammatory cytokine genes in bovine oviduct epithelium using a multilayer response surface method. Sci Rep. 2019;9(1):3189. doi:10.1038/s41598-019-39081-w.
   PubMedGoogle Scholar
• Diez-Roux AV. Multilevel analysis in public health research. Annu Rev Public Health. 2000;21(1):171–192. doi:10.1146/annurev.publhealth.21.1.171.
   PubMed Web of Science ®Google Scholar
• Tadikamalla P, Durcikova A. Statistical models (non-optimization models). In: Bidgoli H, ed., Encyclopedia of Information Systems. University of Pittsburgh, USA: Elsevier; 2003: 227–241 doi:10.1016/B0-12-227240-4/00169-6.
   Google Scholar
• Kowsar R, Mansouri A, Sadeghi N, et al. A multilevel analysis identifies the different relationships between amino acids and the competence of oocytes matured individually or in groups. Sci Rep. 2020;10(1):16082. doi:10.1038/s41598-020-73225-7.
   PubMed Web of Science ®Google Scholar
• Kowsar R, Iranshahi VN, Sadeghi N, Riasi A, Miyamoto A. Urea influences amino acid turnover in bovine cumulus-oocyte complexes, cumulus cells and denuded oocytes, and affects in vitro fertilization outcome. Sci Rep. 2018;8(1):12191. doi:10.1038/s41598-018-30774-2.
   PubMedGoogle Scholar
• Feizi LK, Soleymanian Zad S, Jalali SAH, et al. Fermented soybean meal affects the ruminal fermentation and the abundance of selected bacterial species in holstein calves: a multilevel analysis. Sci Rep. 2020;10(1):12062. doi:10.1038/s41598-020-68778-6.
   PubMed Web of Science ®Google Scholar
• Duarte FG, da Silva Moreira S, Almeida MDCC, de Souza Teles CA, Andrade CS, Reingold AL, et al. Sex differences and correlates of poor glycaemic control in type 2 diabetes: a cross-sectional study in Brazil and Venezuela. BMJ Open. 2019;9(3):e023401. doi:10.1136/bmjopen-2018-023401.
   PubMed Web of Science ®Google Scholar
• Droumaguet C, Balkau B, Simon D, et al. Use of HbA1c in predicting progression to diabetes in French men and women: data from an epidemiological study on the insulin resistance syndrome (DESIR). Diabetes Care. 2006;29(7):1619–1625. doi:10.2337/dc05-2525.
   PubMed Web of Science ®Google Scholar
• Huang SH, Huang PJ, Li JY, Su YD, Lu CC, Shih CL. Hemoglobin A1c levels associated with age and gender in Taiwanese adults without prior diagnosis with diabetes. Int J Environ Res Public Health. 2021;18(7):3390. doi:10.3390/ijerph18073390.
   PubMed Web of Science ®Google Scholar
• Kim C. Does menopause increase diabetes risk? Strategies for diabetes prevention in midlife women. Women’s Health. 2012;8(2):155–167. doi:10.2217/WHE.11.95.
   PubMedGoogle Scholar
• Hana GY, Ali AI, Donia SS, Shaban AM. A study on the effect of estrogen on the insulin signaling pathway in diabetic rats. Menoufia Med J. 2017;30(4):4. doi:10.4103/mmj.mmj_57_17.
   Google Scholar
• Verhagen C, Janssen J, Biessels GJ, Johansen OE, Exalto LG. Females with type 2 diabetes are at higher risk for accelerated cognitive decline than males: CAROLINA-COGNITION study. Nutr Metab Cardiovasc Dis. 2022;32(2):355–364. doi:10.1016/j.numecd.2021.10.013.
   PubMed Web of Science ®Google Scholar
• Farbstein D, Levy AP. HDL dysfunction in diabetes: causes and possible treatments. Expert Rev Cardiovasc Ther. 2012;10(3):353–361. doi:10.1586/erc.11.182.
   PubMedGoogle Scholar
• Kundu D, Saikia M, Paul T. Study of the correlation between total lipid profile and glycosylated hemoglobin among the indigenous population of Guwahati. Int J Life Sci Scienti Res. 2017;3(4):1175–1180. doi:10.21276/ijlssr.2017.3.4.13.
   Google Scholar
• Naqvi S, Naveed S, Ali Z, et al. Correlation between glycated hemoglobin and triglyceride level in type 2 diabetes mellitus. Cureus. 2017;9:e1347. doi:10.7759/cureus.1347.
   PubMed Web of Science ®Google Scholar
• Li M, Wang Y, Liu Z, et al. Females with type 2 diabetes mellitus are prone to diabetic retinopathy: a twelve-province cross-sectional study in china. J Diabetes Res. 2020;2020:1–9. doi:10.1155/2020/5814296.
   Google Scholar
• Awa WL, Fach E, Krakow D, et al. Type 2 diabetes from pediatric to geriatric age: analysis of gender and obesity among 120 183 patients from the German/Austrian DPV database. Eur J Endocrinol. 2012;167(2):245–254. doi:10.1530/EJE-12-0143.
   PubMed Web of Science ®Google Scholar
• Pradeepa R, Anitha B, Mohan V, Ganesan A, Rema M. Risk factors for diabetic retinopathy in a South Indian type 2 diabetic population-the Chennai Urban Rural Epidemiology Study (CURES) eye Study 4. Diabet Med. 2008;25(5):536–542. doi:10.1111/j.1464-5491.2008.02423.x.
   PubMed Web of Science ®Google Scholar
• Zhang X, Saaddine JB, Chou CF, et al. Prevalence of diabetic retinopathy in the United States, 2005-2008. JAMA. 2010;304(6):649–656. doi:10.1001/jama.2010.1111.
   PubMed Web of Science ®Google Scholar
• Cherchi S, Gigante A, Spanu MA, Contini P, Meloni G, Fois MA, et al. Sex-Gender Differences in Diabetic Retinopathy. Diabetology. 2020;1(1):1–10. doi:10.3390/diabetology1010001.
   Google Scholar
• Yau JW, Rogers SL, Kawasaki R, et al. Global prevalence and major risk factors of diabetic retinopathy. Diabetes Care. 2012;35(3):556–564. doi:10.2337/dc11-1909.
   PubMed Web of Science ®Google Scholar
• Nittala MG, Keane PA, Zhang K, Sadda SR. Risk factors for proliferative diabetic retinopathy in a Latino American population. Retina. 2014;34(8):1594–1599. doi:10.1097/IAE.0000000000000117.
   PubMed Web of Science ®Google Scholar
• Kajiwara A, Miyagawa H, Saruwatari J, et al. Gender differences in the incidence and progression of diabetic retinopathy among Japanese patients with type 2 diabetes mellitus: a clinic-based retrospective longitudinal study. Diabetes Res Clin Pract. 2014;103(3):e7–10. doi:10.1016/j.diabres.2013.12.043.
   PubMed Web of Science ®Google Scholar
• Stratton IM, Kohner EM, Aldington SJ, et al. UKPDS 50: risk factors for incidence and progression of retinopathy in type II diabetes over 6 years from diagnosis. Diabetologia. 2001;44(2):156–163. doi:10.1007/s001250051594.
   PubMed Web of Science ®Google Scholar
• Kuzmicki M, Telejko B, Wawrusiewicz-Kurylonek N, et al. The expression of genes involved in NF-κB activation in peripheral blood mononuclear cells of patients with gestational diabetes. Eur J Endocrinol. 2013;168(3):419–427. doi:10.1530/EJE-12-0654.
   PubMed Web of Science ®Google Scholar
• de Mello VD, Kolehmainen M, Pulkkinen L, et al. Downregulation of genes involved in NFκB activation in peripheral blood mononuclear cells after weight loss is associated with the improvement of insulin sensitivity in individuals with the metabolic syndrome: the GENOBIN study. Diabetologia. 2008;51(11):2060–2067. doi:10.1007/s00125-008-1132-7.
   PubMed Web of Science ®Google Scholar
• de Mello VD, Kolehmainen M, Schwab U, et al. Effect of weight loss on cytokine messenger RNA expression in peripheral blood mononuclear cells of obese subjects with the metabolic syndrome. Metabolism. 2008;57(2):192–199. doi:10.1016/j.metabol.2007.08.024.
   PubMed Web of Science ®Google Scholar
• Singel KL, Segal BH. NOX2-dependent regulation of inflammation. Clin Sci. 2016;130(7):479–490. doi:10.1042/CS20150660.
   PubMed Web of Science ®Google Scholar
• Panagi L, Poole L, Hackett RA, Steptoe A. Sex differences in interleukin-6 stress responses in people with type 2 diabetes. Psychophysiol. 2019;56(6):e13334. doi:10.1111/psyp.13334.
   PubMed Web of Science ®Google Scholar
• Jankord R, Turk JR, Schadt JC, et al. Sex difference in link between interleukin-6 and stress. Endocrinology. 2007;148(8):3758–3764. doi:10.1210/en.2006-1650.
   PubMed Web of Science ®Google Scholar
• Payette C, Blackburn P, Lamarche B, et al. Sex differences in postprandial plasma tumor necrosis factor–α, interleukin-6, and C-reactive protein concentrations. Metabolism. 2009;58(11):1593–1601. doi:10.1016/j.metabol.2009.05.011.
   PubMed Web of Science ®Google Scholar
• Bowker N, Shah RL, Sharp SJ, et al. Meta-analysis investigating the role of interleukin-6 mediated inflammation in type 2 diabetes. EBioMedicine. 2020;61:103062. doi:10.1016/j.ebiom.2020.103062.
   PubMed Web of Science ®Google Scholar
• Navarro-Gonzalez J, Mora-Fernandez C, Gomez-Chinchon M, Muros M, Herrera H, Garcia J. Serum and gene expression profile of tumor necrosis factor-alpha and interleukin-6 in hypertensive diabetic patients: effect of amlodipine administration. Int J Immunopathol Pharmacol. 2010;23(1):51–59. doi:10.1177/039463201002300105.
   PubMed Web of Science ®Google Scholar
• Rojas M, Zhang W, Lee DL, et al. Role of IL-6 in Angiotensin II–Induced Retinal Vascular Inflammation. Invest Ophthalmol Vis Sci. 2010;51(3):1709–1718. doi:10.1167/iovs.09-3375.
   PubMed Web of Science ®Google Scholar
• Yao Y, Li R, Du J, Long L, Li X, Luo N. Interleukin-6 and diabetic retinopathy: a systematic review and meta-analysis. Curr Eye Res. 2019;44(5):564–574. doi:10.1080/02713683.2019.1570274.
   PubMed Web of Science ®Google Scholar
• Sen A, Paine SK, Chowdhury IH, et al. Impact of interleukin-6 promoter polymorphism and serum interleukin-6 level on the acute inflammation and neovascularization stages of patients with Eales’ disease. Mol Vis. 2011;17:2552–2563.
   PubMed Web of Science ®Google Scholar
• Slieker RC, van der Heijden AAWA, van Leeuwen N, et al. HbA1c is associated with altered expression in blood of cell cycle- and immune response-related genes. Diabetologia. 2018;61(1):138–146. doi:10.1007/s00125-017-4467-0.
   PubMed Web of Science ®Google Scholar
• Walker AJ, Price JB, Borreggine K, et al. Insulin-stimulated mTOR activation in peripheral blood mononuclear cells associated with early treatment response to lithium augmentation in rodent model of antidepressant-resistance. Transl Psychiatry. 2019;9(1):113. doi:10.1038/s41398-019-0434-5.
   PubMedGoogle Scholar
• Tiittanen M, Huupponen JT, Knip M, Vaarala O. Insulin treatment in patients with type 1 diabetes induces upregulation of regulatory T-cell markers in peripheral blood mononuclear cells stimulated with insulin in vitro. Diabetes. 2006;55(12):3446–3454. doi:10.2337/db06-0132.
   PubMed Web of Science ®Google Scholar
• Al Dubayee MS, Alayed H, Almansour R, et al. Differential expression of human peripheral mononuclear cells phenotype markers in type 2 diabetic patients and type 2 diabetic patients on metformin. Front Endocrinol. 2018;9:537. doi:10.3389/fendo.2018.00537.
   PubMed Web of Science ®Google Scholar
• de Melo Rêgo MJB, Azoubel-Antunes A, Bezerra B, et al. Ability of two new thiazolidinediones to downregulate proinflammatory cytokines in peripheral blood mononuclear cells from children with asthma. Braz J Pharm Sci. 2018;54(3). doi:10.1590/s2175-97902018000300049.
   Web of Science ®Google Scholar
• Verma S, Chandra H, Banerjee M. Cyclooxygenase 1 (COX1) expression in type 2 diabetes mellitus: a preliminary study from north India. Egyp J Med Hum Genet. 2016;17(1):41–45. doi:10.1016/j.ejmhg.2015.07.003.
   Google Scholar
• Kiritoshi S, Nishikawa T, Sonoda K, et al. Reactive oxygen species from mitochondria induce cyclooxygenase-2 gene expression in human mesangial cells: potential role in diabetic nephropathy. Diabetes. 2003;52(10):2570–2577. doi:10.2337/diabetes.52.10.2570.
   PubMed Web of Science ®Google Scholar
• Jiao Q, Ke Q, Li W, et al. Effect of inflammatory factor-induced cyclo-oxygenase expression on the development of reperfusion-related no-reflow phenomenon in acute myocardial infarction. Clin Exp Pharmacol Physiol. 2015;42(2):162–170. doi:10.1111/1440-1681.12339.
   PubMed Web of Science ®Google Scholar
• Pfützner A, Schöndorf T, Hanefeld M, Forst T. High-sensitivity C-reactive protein predicts cardiovascular risk in diabetic and nondiabetic patients: effects of insulin-sensitizing treatment with pioglitazone. J Diabetes Sci Technol. 2010;4(3):706–716. doi:10.1177/193229681000400326.
   PubMedGoogle Scholar
• Li HM, Huang Q, Tang F, Altered NCF2 ZT. NOX2 mRNA expression levels in peripheral blood mononuclear cells of pulmonary tuberculosis patients. Int J Gen Med. 2021;14:9203–9209. doi:10.2147/IJGM.S339194.
   PubMed Web of Science ®Google Scholar
• Wang X, Cheng Z. Cross-sectional studies: strengths, weaknesses, and recommendations. Chest. 2020;158(1):65–71. doi:10.1016/j.chest.2020.03.012.
   PubMed Web of Science ®Google Scholar
• Suomi T, Starskaia I, Kalim UU, et al. Gene expression signature predicts rate of type 1 diabetes progression. EBioMedicine. 2023;92:104625. doi:10.1016/j.ebiom.2023.104625.
   PubMed Web of Science ®Google Scholar
• Fachim HA, Loureiro CM, Siddals K, et al. Circulating microRNA changes in patients with impaired glucose regulation. Adipocyte. 2020;9(1):443–453. doi:10.1080/21623945.2020.1798632.
   PubMed Web of Science ®Google Scholar
• Qureshi N, Desousa J, Siddiqui AZ, Drees BM, Morrison DC, Qureshi AA. Dysregulation of gene expression of key signaling mediators in PBMCs from people with type 2 diabetes mellitus. Int J Mol Sci. 2023;24(3):2732. doi:10.3390/ijms24032732.
   PubMed Web of Science ®Google Scholar